By Product Type
By Research Area
Recombinant viral and human proteins against SARS-CoV-2 proteins
Recombinant viral and human proteins are critical reagents for investigating the novel coronavirus and developing COVID-19 treatments. Proteintech offers high purity, recombinant proteins such as human ACE2 and the viral receptor binding domain (RBD) of the Spike protein (S protein) to further accelerate COVID-19 research.
SARS-CoV-2 has 4 structural components: 1) the Envelope protein (E protein), 2) Membrane glycoprotein (M protein), 3) S protein, and 4) Nucleocapsid protein (N protein). The RBD of S protein binds to Angiotensin converting enzyme-2 (ACE2) on the human cell surface to initiate viral entry. The N protein promotes helical nucleocapsid formation during viral assembly while the E and M proteins are the key structural components of SARS-CoV-2.
|nucleocapsid phosphoprotein||1-419aa||ag30676||6*His tag||BL21(DE3)|
|membrane glycoprotein||101-222aa||ag30692||6*His tag||BL21(DE3)|
|ACE2 (Binding domain) fusion protein||30-356aa||ag30683||6*His tag||PET28a|
|ACE2 (C-terminal) fusion protein||392-744aa||ag15554||6*His tag||PET28a|
|ACE2 fusion protein||30-356aa||ag30686||GST||PGEX-4T|